Larimar Therapeutics
LRMR
87 hedge funds and large institutions have $126M invested in Larimar Therapeutics in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 32 closing their positions.
199% more call options, than puts
Call options by funds: $2.71M | Put options by funds: $906K
4% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 25
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
9% less funds holding
Funds holding: 96 → 87 (-9)
25% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 32
81% less capital invested
Capital invested by funds: $655M → $126M (-$529M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$21.6M |
| 2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$9.06M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.72M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$5.65M |
| 5 |
CC
Clearline Capital
New York
|
+$5.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$41.2M |
| 2 |
Jennison Associates
New York
|
-$38.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.3M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
-$19M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$16.4M |
LRMR Hedge Fund Activity: Q4 2015 in Review
87 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q4 2015, worth a combined $126M — down 81% from $655M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of LRMR and 24 opened new positions — a net loss of 8 holders — while 25 trimmed existing stakes and 26 added.
The largest buyer was State Street, opening a new position worth an estimated $21.6M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $41.2M sold.
- 87 institutional investors held Larimar Therapeutics (LRMR) as of Q4 2015, down from 96 in Q3 2015.
- Funds reported $126M of Larimar Therapeutics stock for Q4 2015, down 81% quarter-over-quarter.
- 24 funds opened new Larimar Therapeutics positions in Q4 2015 and 32 closed out, a net change of -8 holders.
- The largest Larimar Therapeutics buyer in Q4 2015 was State Street, an estimated $21.6M added.
- The largest Larimar Therapeutics seller in Q4 2015 was Janus Henderson Investors US, an estimated $41.2M sold.
Based on aggregated 13F filings for Q4 2015.